InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (3 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
3
T+90 hit rate
0%
T+90 mean return
-30.8%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Posard Matthew L., Director. Director active across 3 companies, notably Halozyme Therapeutics, INC.. Aggregated, 12 filings have been logged. Breakdown: 1 buy · 3 sells. Total volume traded: €1.6m. History available since 5 May 2021. The latest transaction was disclosed on 1 May 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Posard Matthew L.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
4,165 shares0Common StockSEC:0001415889-25-011777:0
10,000 shares@ US$55.72333.2% of flowCommon StockSEC:0001415889-24-021305:0
10,000 shares@ US$50.01130.4% of flowCommon StockSEC:0001415889-24-016672:0
6,501 shares0Common StockSEC:0001415889-24-011705:0
35,714 shares0Common StockSEC:0001209191-23-034582:0
8,065 shares0Common StockSEC:0001415889-23-007694:0
10,000 shares@ US$58.8036.4% of flowCommon StockSEC:0001415889-22-012142:0
26,480 shares0Common StockSEC:0001209191-22-032989:0
6,206 shares0Restricted Stock UnitsSEC:0001179110-22-002912:0
20,000 shares@ US$4.570.033% mcap50.0% of flowCommon StockSEC:0001808805-21-000026:0
Canonical exit: 28 Feb 2022 (T+90)
4,497 shares0Common StockSEC:0001209191-21-036712:0
5,230 shares0Restricted Stock UnitsSEC:0001179110-21-004974:0
12 of 12 declarations
About Posard Matthew L.
Posard Matthew L. is a Director at HALOZYME THERAPEUTICS, INC., DermTech, Inc., and Nautilus Biotechnology, Inc. He plays a key role in the governance of these companies, contributing to strategic decision-making and overseeing operations. His experience in the biopharmaceutical sector is a valuable asset.
